Anemia Treatment Market

The anemia treatment market is reported to reach a valuation of USD 12.45 billion in 2025 to USD 22.08 billion by 2035. Demand for animea treatment is expected to rise at a CAGR of 5.9% over the forecast period. Normocytic anemia is expected to hold 71.3% share in 2025, attributed to high prevalence of normocytic anemia. injectable route will dominate the route of administration segment with a 58.6% market share, owing to higher efficacy and fast acting treatment.